Showing results (361-370 of 726) with videos related to
Sort By:
Pageof 73
Bone Marrow Transplantation|November 11, 1999
High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breastL Schwartzberg, C Weaver, L Lewkow, et al.Breast Cancer (Dove Medical Press)|December 21, 2016
Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter studyShannon Puhalla, Sharon Wilks, Adam M Brufsky, et al.Journal of Medical Economics|October 10, 2012
Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastasesMark S Walker, Paul J E Miller, Madhav Namjoshi, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2004
The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expressionJill M Mooney, Jennifer Klem, Christoph Wülfing, et al.Genomics|February 28, 2002
A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 miceAndrew P Makrigiannis, Amanda T Pau, Pamela L Schwartzberg, et al.Immunological Reviews|July 13, 2007
Tec kinases, actin, and cell adhesionJulio Gomez-Rodriguez, Julie A Readinger, Irene C Viorritto, et al.The Journal of Biological Chemistry|January 27, 1995
Identification of Rlk, a novel protein tyrosine kinase with predominant expression in the T cell lineageQ Hu, D Davidson, P L Schwartzberg, et al.Medical Oncology (Northwood, London, England)|June 3, 2017
Expanding the search for significant EGFR mutations in NSCLC outside of the tyrosine kinase domain with next-generation sequencingMatthew K Stein, Lindsay Morris, Jennifer L Sullivan, et al.Journal of Managed Care & Specialty Pharmacy|April 25, 2018
Clinical Outcomes of Treatment with Filgrastim Versus a Filgrastim Biosimilar and Febrile Neutropenia-Associated Costs Among Patients with Nonmyeloid Cancer Undergoing ChemotherapyLee S Schwartzberg, Lincy S Lal, Sanjeev Balu, et al.OTJR : Occupation, Participation and Health|August 5, 2022
Occupational Therapy: An Essential Component of Support for Young Children With CancerJessica Sparrow, Hannah Dagen, Allison Harris, et al.Pageof 73